Detalhe da pesquisa
1.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470866
2.
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge.
PLoS Pathog
; 16(9): e1008764, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881968
3.
Liposome Formulations as Adjuvants for Vaccines.
Curr Top Microbiol Immunol
; 433: 1-28, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33165871
4.
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.
Immunity
; 38(1): 176-86, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313589
5.
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
PLoS Pathog
; 13(7): e1006510, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28759651
6.
Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
PLoS Pathog
; 13(9): e1006620, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910384
7.
Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.
J Infect Dis
; 218(10): 1541-1550, 2018 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893872
8.
Designing a soluble near full-length HIV-1 gp41 trimer.
J Biol Chem
; 288(1): 234-46, 2013 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23184960
9.
Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population.
EBioMedicine
; 94: 104683, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37413891
10.
Analytical validation of quantitative SARS-CoV-2 subgenomic and viral load laboratory developed tests conducted on the Panther Fusion® (Hologic) with preliminary application to clinical samples.
PLoS One
; 18(6): e0287576, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384714
11.
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.
Front Immunol
; 13: 901217, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711449
12.
HIV-1 infected humanized DRAGA mice develop HIV-specific antibodies despite lack of canonical germinal centers in secondary lymphoid tissues.
Front Immunol
; 13: 1047277, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505432
13.
Validation of SARS-CoV-2 pooled testing for surveillance using the Panther Fusion® system: Impact of pool size, automation, and assay chemistry.
PLoS One
; 17(11): e0276729, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342921
14.
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
Sci Transl Med
; 14(632): eabi5735, 2022 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914540
15.
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model.
Vaccines (Basel)
; 10(5)2022 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35632473
16.
Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.
J Liposome Res
; 21(4): 279-85, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21401373
17.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
bioRxiv
; 2021 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851155
18.
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates.
bioRxiv
; 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791694
19.
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates.
iScience
; 24(2): 102047, 2021 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554060
20.
Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.
J Virol
; 83(14): 7049-61, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19403671